— Know what they know.
Not Investment Advice
Also trades as: PHM.MC (BME) · $vol 5M · 0RC6.L (LSE) · $vol 0M

PHMMF OTC

Pharma Mar, S.A.
1W: +0.0% 1M: +0.0% 3M: +19.0% YTD: +9.7% 1Y: -7.5% 3Y: +193.2% 5Y: +10.3%
$94.60
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 62 · $1.6B mcap · 13M float · 0.0001% daily turnover · Short 87% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
3
ROE
5
ROA
5
D/E
2
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PHMMF receives an overall rating of B+. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-01 A- B+
2026-06-30 None ADDED
2026-06-17 EXISTED None
2026-06-12 None ADDED
2026-04-18 EXISTED None
2026-04-13 None ADDED
2026-04-11 EXISTED None
2026-04-06 None ADDED
2026-04-05 EXISTED None
2026-03-31 None ADDED

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A
Profitability
55
Balance Sheet
96
Earnings Quality
71
Growth
71
Value
—
Momentum
90
Safety
—
Cash Flow
83

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓
Beneish M-Score
-2.68
Unlikely Manipulator
Ohlson O-Score
-9.03
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 81.2/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.11x
Accruals: -1.6%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PHMMF scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PHMMF's score of -2.68 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PHMMF's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PHMMF receives an estimated rating of AA- (score: 81.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PHMMF's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
21.88x
PEG
0.59x
P/S
5.66x
P/B
4.94x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$32.48
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 21.9x earnings, PHMMF commands a growth premium. Graham's intrinsic value formula yields $32.48 per share, 191% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.378
NI / EBT
×
Interest Burden
1.149
EBT / EBIT
×
EBIT Margin
0.162
EBIT / Rev
×
Asset Turnover
0.590
Rev / Assets
×
Equity Multiplier
1.640
Assets / Equity
=
ROE
24.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PHMMF's ROE of 24.9% is driven by Asset Turnover (0.590), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.38 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$124.82
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PHMMF's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. PHMMF actually compounded EPS at 40.8% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. PHMMF trades at a premium to its adjusted intrinsic value of $124.82, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 21.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$94.60
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
2087.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 50.4% 66.2% 55.1% 49.5% 48.4% 24.6% 13.8% 10.0% 4.5% 0.5% 1.0% -0.9% 0.3% 13.0% 10.2% 21.9% 17.9% 32.6% 36.0% 24.9% 24.85%
ROA 18.0% 26.6% 25.1% 23.1% 23.7% 13.0% 7.7% 5.6% 2.6% 0.3% 0.6% -0.5% 0.2% 7.6% 6.0% 12.6% 10.1% 20.2% 22.4% 15.2% 15.15%
ROIC -2.7% 3.6% 3.2% 2.1% 1.1% 60.9% 43.6% 48.1% 33.4% -4.2% -6.1% -9.6% -4.9% 11.1% 11.1% 32.2% 26.6% 51.3% 56.2% 35.9% 35.87%
ROCE 24.4% 36.6% 33.5% 27.2% 30.4% 14.6% 7.5% 6.7% 2.2% -1.7% -2.4% -3.8% -1.1% 5.8% 6.6% 15.2% 11.9% 19.0% 20.6% 12.0% 12.02%
Gross Margin 92.0% 94.0% 92.9% 92.5% 1.0% 88.7% 93.7% 95.9% 91.6% 94.0% 95.4% 92.8% 95.6% 97.3% 91.2% 95.1% 87.9% 93.6% 91.5% 90.5% 90.46%
Operating Margin 1.1% 50.5% 35.8% 15.5% 29.7% 12.0% -7.8% 8.8% -0.5% -12.8% -11.3% -1.7% 12.0% 10.1% -7.9% 42.8% -17.3% 44.5% 1.4% -2.8% -2.83%
Net Margin 25.4% 44.4% 41.3% 26.8% 32.6% 2.5% 4.2% 10.9% 4.1% -16.8% 6.1% 2.9% 8.6% 38.6% -10.2% 41.4% -11.2% 65.9% 3.6% -2.0% -1.96%
EBITDA Margin 27.7% 49.0% 38.6% 18.8% 18.6% 9.9% -3.6% 11.9% 2.6% -8.9% -7.3% 6.7% 15.3% 31.4% -2.8% 46.4% -5.6% 46.8% 6.3% 1.4% 1.41%
FCF Margin 14.9% 7.8% 17.4% 17.8% 15.9% 15.0% 0.9% -8.0% -17.0% -18.6% -21.5% -18.7% -10.6% -5.4% -10.4% 0.7% 9.1% 19.8% 25.6% 23.4% 23.38%
OCF Margin 18.2% 11.2% 20.3% 20.5% 18.2% 19.5% 5.7% -0.4% -7.4% -8.5% -7.3% -6.0% 1.0% 3.4% -5.4% 4.6% 11.9% 24.0% 30.2% 28.5% 28.46%
ROE 3Y Avg snapshot only 14.10%
ROE 5Y Avg snapshot only 18.62%
ROA 3Y Avg snapshot only 8.60%
ROIC 3Y Avg snapshot only 33.71%
ROIC Economic snapshot only 15.68%
Cash ROA snapshot only 15.81%
Cash ROIC snapshot only 48.72%
CROIC snapshot only 40.02%
NOPAT Margin snapshot only 20.95%
Pretax Margin snapshot only 18.65%
R&D / Revenue snapshot only 43.45%
SGA / Revenue snapshot only 27.17%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 21.882
P/S Ratio — — — — — — — — — — — — — — — — — — — — 5.657
P/B Ratio — — — — — — — — — — — — — — — — — — — — 4.936
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.592
Graham Number snapshot only $32.48
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.45 3.42 3.59 2.86 2.96 2.83 2.89 3.13 3.01 2.63 2.62 2.55 2.66 3.03 2.97 2.84 2.73 3.02 3.06 2.85 2.855
Quick Ratio 3.32 3.30 3.39 2.67 2.72 2.54 2.53 2.72 2.61 2.22 2.14 2.01 2.13 2.41 2.33 2.28 2.14 2.44 2.47 2.35 2.351
Debt/Equity 0.38 0.28 0.24 0.22 0.20 0.19 0.20 0.21 0.21 0.23 0.21 0.22 0.21 0.25 0.26 0.26 0.25 0.20 0.19 0.18 0.183
Net Debt/Equity -1.16 -0.86 -0.86 -0.73 -0.68 -0.63 -0.64 -0.67 -0.63 -0.61 -0.62 -0.53 -0.58 -0.50 -0.45 -0.38 -0.49 -0.46 -0.48 -0.49 -0.491
Debt/Assets 0.16 0.13 0.13 0.11 0.11 0.11 0.12 0.12 0.12 0.13 0.12 0.12 0.12 0.15 0.16 0.15 0.15 0.13 0.12 0.12 0.116
Debt/EBITDA 0.77 0.49 0.49 0.53 0.54 1.00 2.10 2.55 4.09 27.14 649.35 -15.47 11.07 2.29 2.17 1.09 1.32 0.77 0.69 1.05 1.048
Net Debt/EBITDA -2.35 -1.53 -1.80 -1.81 -1.82 -3.29 -6.75 -8.25 -12.26 -73.89 -1926.76 37.61 -30.48 -4.64 -3.71 -1.62 -2.52 -1.78 -1.74 -2.81 -2.814
Interest Coverage 9.62 10.35 9.38 7.77 7.76 7.40 4.34 6.59 9.11 -2.07 -4.36 -6.37 -1.97 6.29 5.10 9.69 7.17 19.58 28.93 27.07 27.067
Equity Multiplier 2.43 2.07 1.87 1.89 1.78 1.76 1.72 1.71 1.69 1.76 1.73 1.75 1.83 1.68 1.69 1.73 1.73 1.57 1.54 1.57 1.570
Cash Ratio snapshot only 1.716
Debt Service Coverage snapshot only 33.345
Cash to Debt snapshot only 3.684
FCF to Debt snapshot only 1.115
Defensive Interval snapshot only 474.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.57 0.66 0.64 0.63 0.63 0.52 0.47 0.47 0.47 0.43 0.46 0.47 0.49 0.51 0.53 0.57 0.53 0.59 0.63 0.59 0.590
Inventory Turnover 1.64 1.46 1.17 1.11 0.79 0.71 0.50 0.38 0.47 0.29 0.24 0.25 0.23 0.18 0.21 0.20 0.23 0.31 0.32 0.37 0.374
Receivables Turnover 7.17 6.19 8.04 7.79 8.24 4.94 6.41 6.05 5.82 5.63 6.31 5.68 5.23 5.69 5.52 5.52 5.34 6.01 5.88 5.08 5.078
Payables Turnover 0.89 0.69 0.61 0.85 0.50 0.50 0.51 0.43 0.51 0.34 0.33 0.37 0.33 0.24 0.26 0.27 0.30 0.35 0.39 0.49 0.487
DSO 51 59 45 47 44 74 57 60 63 65 58 64 70 64 66 66 68 61 62 72 71.9 days
DIO 222 249 312 330 464 512 737 966 769 1273 1502 1445 1618 2011 1747 1858 1557 1175 1142 976 976.2 days
DPO 408 533 601 430 729 728 723 853 714 1076 1099 977 1106 1513 1424 1342 1221 1041 946 749 749.2 days
Cash Conversion Cycle -135 -224 -243 -54 -220 -142 71 173 117 262 460 533 582 563 389 582 404 195 258 299 298.9 days
Fixed Asset Turnover snapshot only 3.642
Operating Cycle snapshot only 1048.1 days
Cash Velocity snapshot only 1.295
Capital Intensity snapshot only 1.800
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -21.9% -14.9% 4.5% 16.6% 18.5% -14.6% -23.6% -24.7% -24.1% -19.5% -8.5% -9.3% -3.2% 10.6% 8.4% 19.2% 7.4% 26.6% 28.3% 15.5% 15.54%
Net Income -58.5% -32.3% -0.2% 26.9% 41.5% -46.8% -68.2% -75.3% -89.1% -97.7% -93.0% -1.1% -93.3% 22.0% 8.8% 24.9% 53.8% 1.9% 3.1% 33.8% 33.79%
EPS -58.2% -31.8% 0.5% 26.9% 41.5% -46.8% -68.4% -75.3% -89.1% -97.6% -92.7% -1.1% -93.2% 22.0% 8.9% 25.3% 54.5% 1.9% 3.1% 33.5% 33.53%
FCF -89.2% -93.5% -64.1% 1.2% 26.6% 64.9% -96.2% -1.3% -1.8% -2.0% -23.4% -1.1% 39.7% 67.7% 47.4% 1.0% 1.9% 5.6% 4.2% 38.9% 38.91%
EBITDA -51.3% -35.8% -10.6% 2.1% 11.7% -57.5% -78.5% -79.7% -86.5% -96.2% -99.7% -1.1% -67.4% 12.9% 385.9% 19.6% 10.0% 1.9% 1.9% -7.5% -7.47%
Op. Income -33.1% -40.7% -9.8% 1.9% 20.6% -51.4% -75.0% -83.3% -90.4% -1.1% -1.2% -1.5% -1.6% 2.3% 2.2% 4.0% 5.2% 9.3% 8.0% 5.9% 5.95%
OCF Growth snapshot only 6.07%
Asset Growth snapshot only 13.02%
Equity Growth snapshot only 24.43%
Debt Growth snapshot only -10.82%
Shares Change snapshot only 0.19%
Dividend Growth snapshot only -1.00%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 3.6% 12.3% 19.1% 34.0% 35.6% 31.8% 2.2% -6.4% -11.1% -16.3% -9.9% -7.3% -4.5% -8.7% -8.8% -6.6% -7.6% 4.1% 8.4% 7.7% 7.69%
Revenue 5Y 6.6% 4.9% 4.7% 4.6% 4.6% 1.8% -0.1% -1.6% 0.0% -0.5% 3.4% 10.4% 12.9% 15.3% 1.2% -2.4% -6.1% -3.9% 0.3% 1.8% 1.85%
EPS 3Y — — — — — — -25.0% -44.6% -59.9% -79.6% -71.5% — -78.1% -34.0% -38.9% -19.7% -25.8% 16.8% 43.3% 40.8% 40.83%
EPS 5Y — — — — — — — — — — — — — — -21.2% -18.7% -24.7% -10.4% -1.3% -2.6% -2.61%
Net Income 3Y — — — — — — -25.5% -44.8% -60.1% -79.8% -71.9% — -78.3% -34.5% -39.7% -20.8% -26.6% 15.0% 40.9% 39.1% 39.13%
Net Income 5Y — — — — — — — — — — — — — — -22.2% -19.4% -25.3% -11.4% -2.4% -3.4% -3.35%
EBITDA 3Y — — — — — — -32.8% -47.5% -58.1% -78.2% -91.7% — -63.4% -39.4% -37.1% -17.5% -21.5% 15.5% 49.5% 36.7% 36.70%
EBITDA 5Y — — — — — — — — — — — — — — -18.9% -16.7% -23.4% -15.9% -8.5% -11.9% -11.92%
Gross Profit 3Y 9.2% 19.1% 25.2% 37.3% 38.6% 31.4% 1.1% -7.3% -12.2% -16.6% -9.2% -6.6% -3.6% -7.9% -8.6% -6.0% -7.9% 3.9% 8.1% 6.7% 6.68%
Gross Profit 5Y 11.2% 9.3% 9.3% 9.1% 9.5% 6.4% 4.4% 2.7% 3.3% 3.3% 6.7% 12.2% 14.3% 15.6% 0.8% -2.8% -6.5% -4.4% 0.5% 1.9% 1.91%
Op. Income 3Y — — — — 1.2% — -27.9% -43.7% -57.4% — — — — -61.3% -58.7% -35.8% -37.7% 7.0% 36.2% 18.8% 18.83%
Op. Income 5Y — — — — — — — — — — — — — — -36.2% -22.3% -27.9% -18.8% -10.7% -4.0% -4.05%
FCF 3Y — — — — — — -78.7% — — — — — — — — -68.6% -23.4% 14.1% 2.3% — —
FCF 5Y — — 41.6% 71.5% — — — — — — — — — — — -65.3% -42.8% -30.8% -12.5% 21.8% 21.76%
OCF 3Y — — — — — — -60.5% — — — — — -63.8% -38.3% — -43.0% -19.8% 11.5% 88.4% — —
OCF 5Y — — 30.2% 40.9% 62.7% — — — — — — — — — — -49.1% -39.8% -28.2% -10.3% 21.1% 21.06%
Assets 3Y 25.8% 32.7% 31.5% 44.4% 49.9% 46.6% 10.7% 0.6% 2.0% 1.0% -1.1% -2.5% -1.4% -1.7% -4.1% -3.8% -3.3% 0.1% 1.0% 3.1% 3.14%
Assets 5Y 10.7% 10.7% 11.8% 12.0% 13.3% 15.9% 15.0% 13.5% 14.9% 16.6% 15.0% 19.6% 24.2% 22.9% 3.9% -0.2% 0.8% 3.6% 2.2% 2.8% 2.82%
Equity 3Y 64.6% 1.0% 1.6% 10.7% — 1.7% 38.7% 25.1% 28.1% 23.5% 14.7% 10.4% 8.4% 5.4% -0.7% -0.9% -2.3% 4.1% 4.8% 6.0% 6.04%
Book Value 3Y 65.9% 1.0% 1.6% 10.8% — 1.7% 39.7% 25.5% 28.5% 24.7% 16.1% 11.2% 9.1% 6.1% 0.6% 0.5% -1.3% 5.7% 6.6% 7.3% 7.33%
Dividend 3Y 8.4% 8.4% 5.0% — — — — — — — — -0.1% -0.1% -0.1% 0.6% 8.3% 8.1% 8.5% 8.7% — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.22 0.15 0.37 0.23 0.18 0.13 0.12 0.00 0.00 0.01 0.03 0.20 0.30 0.21 0.02 0.39 0.77 0.30 0.01 0.05 0.055
Earnings Stability 0.43 0.67 0.84 0.57 0.47 0.45 0.39 0.18 0.08 0.02 0.00 0.02 0.02 0.06 0.65 0.64 0.65 0.37 0.15 0.12 0.119
Margin Stability 0.89 0.89 0.90 0.91 0.91 0.90 0.90 0.91 0.92 0.92 0.94 0.97 0.97 0.99 0.99 0.98 0.99 0.99 0.99 0.98 0.982
Rev. Growth Consistency 0.00 0.00 1.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0
Earnings Persistence 0.50 0.50 1.00 0.89 0.83 0.81 0.50 0.50 0.50 0.50 0.50 0.20 0.50 0.50 0.50 0.20 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.17 0.61 1.00 0.76 0.66 0.39 0.00 0.00 0.00 0.00 0.00 — 0.00 0.00 0.00 — 0.00 0.03 0.00 0.71 0.711
ROE Trend — 0.35 -0.34 -0.41 -0.55 -0.71 -0.45 -0.35 -0.37 -0.37 -0.28 -0.26 -0.22 0.01 0.03 0.16 0.15 0.23 0.27 0.12 0.125
Gross Margin Trend -0.00 -0.02 -0.00 -0.01 0.01 -0.01 0.00 0.02 -0.01 0.01 0.01 -0.00 0.01 0.02 0.01 0.01 0.00 -0.02 -0.02 -0.03 -0.027
FCF Margin Trend -0.26 -0.26 -0.56 -0.46 -0.45 -0.40 -0.33 -0.22 -0.32 -0.30 -0.31 -0.24 -0.10 -0.04 -0.00 0.14 0.23 0.32 0.42 0.32 0.324
Sustainable Growth Rate 41.0% 58.1% 48.5% 49.5% 48.4% 24.6% 13.8% 4.4% -1.1% -5.1% -4.7% — -5.6% 7.3% 4.3% 14.7% 10.6% 26.6% 29.8% 24.9% 24.85%
Internal Growth Rate 17.1% 30.4% 28.3% 30.0% 31.1% 14.9% 8.3% 2.5% — — — — — 4.5% 2.6% 9.2% 6.3% 19.6% 22.7% 17.9% 17.86%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.57 0.28 0.52 0.56 0.48 0.78 0.35 -0.03 -1.37 -11.83 -5.83 5.44 2.65 0.23 -0.48 0.21 0.62 0.71 0.84 1.11 1.107
FCF/OCF 0.82 0.70 0.86 0.87 0.87 0.77 0.15 19.94 2.29 2.19 2.95 3.10 -10.71 -1.57 1.91 0.15 0.76 0.82 0.85 0.82 0.821
FCF/Net Income snapshot only 0.910
OCF/EBITDA snapshot only 1.423
CapEx/Revenue 3.3% 3.4% 2.9% 2.7% 2.3% 4.5% 4.9% 7.6% 9.6% 10.1% 14.2% 12.7% 11.6% 8.9% 5.0% 4.0% 2.8% 4.2% 4.5% 5.1% 5.08%
CapEx/Depreciation snapshot only 1.350
Accruals Ratio 0.08 0.19 0.12 0.10 0.12 0.03 0.05 0.06 0.06 0.04 0.04 0.02 -0.00 0.06 0.09 0.10 0.04 0.06 0.03 -0.02 -0.016
Sloan Accruals snapshot only 0.034
Cash Flow Adequacy snapshot only 5.602
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 1.40%
Dividend/Share $0.63 $0.63 $0.60 $0.00 $0.00 $0.00 $0.00 $0.65 $0.65 $0.66 $0.67 $0.65 $0.65 $0.65 $0.66 $0.81 $0.80 $0.81 $0.81 $0.00 $1.00
Payout Ratio 18.7% 12.2% 12.0% 0.0% 0.0% 0.0% 0.0% 56.0% 1.3% 10.3% 5.8% — 18.4% 43.7% 57.5% 33.2% 40.9% 18.6% 17.3% 0.0% 0.00%
FCF Payout Ratio 39.8% 63.5% 26.9% 0.0% 0.0% 0.0% 0.0% — — — — — — — — 10.9% 85.8% 31.9% 24.1% 0.0% 0.00%
Total Payout Ratio 1.0% 56.0% 56.4% 53.1% 55.2% 1.0% 2.1% 3.2% 6.2% 43.6% 18.3% — 44.4% 1.2% 1.6% 95.4% 1.0% 42.9% 35.7% 10.9% 10.94%
Div. Increase Streak 1 1 1 — — — — 0 0 0 0 0 0 0 0 0 0 0 0 — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.94 0.98 0.97 0.96 0.96 1.13 1.44 1.68 322.24 -0.31 -0.64 0.28 -0.15 2.18 1.83 1.28 1.37 1.26 1.24 1.38 1.378
Interest Burden (EBT/EBIT) 1.00 0.92 0.94 1.10 1.03 1.02 0.93 0.68 0.00 0.87 0.54 0.74 1.51 0.77 0.65 0.83 0.83 1.04 1.07 1.15 1.149
EBIT Margin 0.34 0.45 0.43 0.35 0.39 0.22 0.12 0.10 0.03 -0.03 -0.04 -0.05 -0.02 0.09 0.10 0.21 0.17 0.26 0.27 0.16 0.162
Asset Turnover 0.57 0.66 0.64 0.63 0.63 0.52 0.47 0.47 0.47 0.43 0.46 0.47 0.49 0.51 0.53 0.57 0.53 0.59 0.63 0.59 0.590
Equity Multiplier 2.81 2.49 2.20 2.15 2.04 1.90 1.80 1.80 1.74 1.76 1.73 1.73 1.76 1.72 1.71 1.74 1.78 1.62 1.61 1.64 1.640
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $3.38 $5.16 $5.03 $4.70 $4.78 $2.74 $1.59 $1.16 $0.52 $0.06 $0.12 $-0.10 $0.04 $1.48 $1.15 $2.43 $1.96 $4.36 $4.68 $3.24 $3.24
Book Value/Share $7.95 $9.88 $11.20 $11.49 $11.80 $12.38 $11.98 $11.70 $11.47 $10.97 $11.00 $10.28 $10.33 $11.81 $11.41 $11.65 $11.35 $14.63 $14.51 $14.47 $14.47
Tangible Book/Share $7.77 $9.70 $11.03 $11.33 $11.65 $12.24 $11.85 $11.57 $11.36 $10.86 $10.91 $10.20 $10.26 $11.76 $11.35 $11.58 $11.28 $14.42 $14.29 $14.23 $14.23
Revenue/Share $10.65 $12.76 $12.87 $12.91 $12.62 $10.90 $9.78 $9.74 $9.60 $8.97 $9.26 $9.00 $9.47 $9.91 $10.16 $10.94 $10.29 $12.87 $13.10 $12.61 $12.61
FCF/Share $1.58 $0.99 $2.24 $2.29 $2.00 $1.64 $0.09 $-0.78 $-1.63 $-1.67 $-1.99 $-1.69 $-1.00 $-0.54 $-1.06 $0.07 $0.93 $2.54 $3.36 $2.95 $2.95
OCF/Share $1.93 $1.43 $2.62 $2.64 $2.29 $2.13 $0.56 $-0.04 $-0.71 $-0.76 $-0.67 $-0.54 $0.09 $0.34 $-0.55 $0.51 $1.22 $3.09 $3.95 $3.59 $3.59
Cash/Share $12.28 $11.21 $12.30 $10.92 $10.35 $10.13 $10.11 $10.29 $9.70 $9.22 $9.12 $7.66 $8.19 $8.76 $8.14 $7.40 $8.43 $9.71 $9.75 $9.74 $9.74
EBITDA/Share $3.93 $5.55 $5.35 $4.67 $4.39 $2.36 $1.14 $0.95 $0.59 $0.09 $0.00 $-0.14 $0.20 $1.26 $1.39 $2.73 $2.20 $3.80 $4.02 $2.52 $2.52
Debt/Share $3.03 $2.74 $2.65 $2.48 $2.36 $2.37 $2.40 $2.43 $2.42 $2.48 $2.30 $2.23 $2.18 $2.90 $3.00 $2.97 $2.89 $2.94 $2.76 $2.64 $2.64
Net Debt/Share $-9.25 $-8.47 $-9.65 $-8.44 $-7.99 $-7.76 $-7.72 $-7.86 $-7.27 $-6.74 $-6.82 $-5.43 $-6.00 $-5.86 $-5.14 $-4.43 $-5.54 $-6.78 $-6.99 $-7.10 $-7.10
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 6 6 6 6 7 4 4 4 3 3 3 1 6 7 5 7 6 6 8 7 7
Beneish M-Score -2.24 -0.40 -1.84 -1.46 -1.33 -2.87 -2.25 -2.61 -2.36 -2.52 -2.43 -2.31 -2.47 -1.37 -1.75 -1.26 -1.94 -1.18 -2.15 -2.68 -2.679
Ohlson O-Score snapshot only -9.035
ROIC (Greenblatt) snapshot only 14.63%
Net-Net WC snapshot only $7.97
EVA snapshot only $33042876.65
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 77.75 81.00 77.75 77.75 77.75 76.25 64.00 65.50 65.00 40.55 40.55 49.55 41.15 65.70 64.05 70.75 75.55 81.50 82.75 81.25 81.250
Credit Grade snapshot only 4
Credit Trend snapshot only 10.500
Implied Spread (bps) snapshot only 100.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms